A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
Saved in:
| Title: | A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis. |
|---|---|
| Authors: | Gu BJ; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia., Field J; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia., Dutertre S; Institut des Biomolécules Max Mousseron, UMR 5247, Université Montpellier 2-CNRS, Montpellier, France., Ou A; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia., Kilpatrick TJ; Melbourne Neuroscience Institute, University of Melbourne, Parkville, Victoria, Australia., Lechner-Scott J; Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia., Scott R; Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia., Lea R; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia., Taylor BV; Menzies Institute, University of Tasmania, Hobart, Tasmania, Australia., Stankovich J; Menzies Institute, University of Tasmania, Hobart, Tasmania, Australia., Butzkueven H; Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia., Gresle M; Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia., Laws SM; School of Medical Sciences, Edith Cowan University, Joondalup, Western Australia, Australia., Petrou S; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia., Hoffjan S; Department of Human Genetics, Ruhr-University Bochum, Bochum, Germany., Akkad DA; Department of Human Genetics, Ruhr-University Bochum, Bochum, Germany., Graham CA; Regional Genetics Laboratories, Belfast Health & Social Care Trust, Northern Ireland, UK., Hawkins S; Department of Neurology, Belfast Health & Social Care Trust, Northern Ireland, UK., Glaser A; Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden., Bedri SK; Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden., Hillert J; Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden., Matute C; CIBERNED, Achucarro Basque Center for Neuroscience, and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain and., Antiguedad A; Servicio de Neurología, Hospital Universitario Basurto-Osakidetza, Bilbao, Spain., Wiley JS; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia, james.wiley@florey.edu.au. |
| Corporate Authors: | ANZgene Consortium |
| Source: | Human molecular genetics [Hum Mol Genet] 2015 Oct 01; Vol. 24 (19), pp. 5644-54. Date of Electronic Publication: 2015 Jul 17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: IRL Press at Oxford University Press Country of Publication: England NLM ID: 9208958 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2083 (Electronic) Linking ISSN: 09646906 NLM ISO Abbreviation: Hum Mol Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
